6.82
price up icon1.04%   0.07
after-market After Hours: 6.90 0.08 +1.17%
loading
Tango Therapeutics Inc stock is traded at $6.82, with a volume of 1.29M. It is up +1.04% in the last 24 hours and up +37.22% over the past month. Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
See More
Previous Close:
$6.75
Open:
$6.74
24h Volume:
1.29M
Relative Volume:
0.46
Market Cap:
$739.25M
Revenue:
$42.51M
Net Income/Loss:
$-116.49M
P/E Ratio:
-6.0893
EPS:
-1.12
Net Cash Flow:
$-120.82M
1W Performance:
+0.74%
1M Performance:
+37.22%
6M Performance:
+124.34%
1Y Performance:
-30.76%
1-Day Range:
Value
$6.68
$7.105
1-Week Range:
Value
$6.36
$7.105
52-Week Range:
Value
$1.03
$12.02

Tango Therapeutics Inc Stock (TNGX) Company Profile

Name
Name
Tango Therapeutics Inc
Name
Phone
(857) 320-4900
Name
Address
201 BROOKLINE AVENUE, BOSTON
Name
Employee
155
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
TNGX's Discussions on Twitter

Compare TNGX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TNGX
Tango Therapeutics Inc
6.82 731.66M 42.51M -116.49M -120.82M -1.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-17-24 Initiated Jefferies Buy
Apr-04-24 Initiated Cantor Fitzgerald Overweight
Feb-12-24 Initiated Piper Sandler Overweight
Dec-08-23 Initiated B. Riley Securities Buy
Oct-20-22 Upgrade H.C. Wainwright Neutral → Buy
Sep-20-21 Initiated SVB Leerink Outperform
View All

Tango Therapeutics Inc Stock (TNGX) Latest News

pulisher
Jul 25, 2025

What drives Tango Therapeutics Inc. stock priceMassive portfolio appreciation - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Will Tango Therapeutics Inc. stock benefit from AI tech trendsSuperior capital gains - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is Tango Therapeutics Inc. a good long term investmentPhenomenal investment performance - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Tango Therapeutics Inc. stockExplosive portfolio gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 22, 2025

Tango Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Optimistic Investors Push Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Up 31% But Growth Is Lacking - 富途牛牛

Jul 22, 2025
pulisher
Jul 22, 2025

Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Tango Therapeutics Earnings Alert: Q2 2025 Results Coming August 5 Without Investor Call - Stock Titan

Jul 22, 2025
pulisher
Jul 19, 2025

Will Tango Therapeutics Inc. stock benefit from interest rate changesMarket Timing Advice - Newser

Jul 19, 2025
pulisher
Jul 19, 2025

How Tango Therapeutics Inc. stock performs during market volatilityFree Consultation - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

How high can Tango Therapeutics Inc. stock price go in 2025Daily Volume Leaders - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Can Tango Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jul 17, 2025
pulisher
Jul 16, 2025

Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Tango Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Tango Therapeutics Inc. stock attracts strong analyst attentionFree Capital Growth Strategies - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Tango Therapeutics (TNGX) Soars 5.96% on Strong Q2 Earnings - AInvest

Jul 09, 2025
pulisher
Jul 07, 2025

Tango Therapeutics’ SWOT analysis: biotech stock’s potential in precision cancer therapies - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 06, 2025

Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? - MSN

Jul 06, 2025
pulisher
Jul 03, 2025

HC Wainwright Issues Optimistic Forecast for TNGX Earnings - Defense World

Jul 03, 2025
pulisher
Jun 30, 2025

Tango Therapeutics, Inc.(NasdaqGM: TNGX) added to Russell 3000 Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

H.C. Wainwright reiterates Buy rating on Tango Therapeutics stock - Investing.com

Jun 30, 2025

Tango Therapeutics Inc Stock (TNGX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):